AQR Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Buy |
49,040
+9,677
| +25% | +$611K | ﹤0.01% | 1533 |
|
|
2025
Q1 | $2.09M | Buy |
39,363
+23,506
| +148% | +$1.25M | ﹤0.01% | 1584 |
|
|
2024
Q4 | $888K | Sell |
15,857
-16,952
| -52% | -$949K | ﹤0.01% | 1949 |
|
|
2024
Q3 | $1.72M | Sell |
32,809
-71,021
| -68% | -$3.72M | ﹤0.01% | 1573 |
|
|
2024
Q2 | $4.26M | Buy |
103,830
+32,831
| +46% | +$1.35M | 0.01% | 1093 |
|
|
2024
Q1 | $3.08M | Buy |
70,999
+56,017
| +374% | +$2.43M | 0.01% | 1220 |
|
|
2023
Q4 | $689K | Sell |
14,982
-5,314
| -26% | -$244K | ﹤0.01% | 1749 |
|
|
2023
Q3 | $465K | Buy |
20,296
+7,580
| +60% | +$174K | ﹤0.01% | 1873 |
|
|
2023
Q2 | $210K | Buy |
+12,716
| New | +$210K | ﹤0.01% | 2070 |
|
|
2022
Q3 | – | Sell |
-10,295
| Closed | -$43K | – | 2305 |
|
|
2022
Q2 | $43K | Buy |
10,295
+164
| +2% | +$685 | ﹤0.01% | 2141 |
|
|
2022
Q1 | $117K | Buy |
+10,131
| New | +$117K | ﹤0.01% | 2127 |
|
|
2021
Q4 | – | Sell |
-10,191
| Closed | -$133K | – | 2267 |
|
|
2021
Q3 | $133K | Buy |
+10,191
| New | +$133K | ﹤0.01% | 2188 |
|